VAPO - Vapotherm, Inc.

NYSE - NYSE Delayed Price. Currency in USD

Vapotherm, Inc.

100 Domain Drive
Exeter, NH 03833
United States

IndustryMedical Devices
Full Time Employees276

Key Executives

NameTitlePayExercisedYear Born
Mr. Joseph F. Army CPACEO, Pres & Director521.04kN/A1964
Mr. William NilandFounderN/AN/AN/A
Mr. John LandryCFO, VP, Sec. & TreasurerN/AN/A1973
Mr. John CoolidgeVP of OperationsN/AN/A1961
Mr. Anthony Ten HaagenVP of Legal & ComplianceN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit and Q50 compressor; and disposable products comprising single-use disposables and nasal interfaces. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.

Corporate Governance

Vapotherm, Inc.’s ISS Governance QualityScore as of October 4, 2019 is 7. The pillar scores are Audit: 2; Board: 8; Shareholder Rights: 6; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.